A study of clinical profile and ophthalmological manifestations of herpes zoster ophthalmicus with HIV seropositivity in Northern Karnataka
Keywords:
Herpes zoster ophthalmicus, ocular, manifestationAbstract
Objective To evaluate the clinical profile and ophthalmological manifestations of herpes zoster ophthalmicus and to identify HIV seropositivity in them.Methods The study was a hospital based observational study. After obtaining an informed oral consent, all subjects in this study were submitted to a full history taking, general medical and dermatological examination, ophthalmological history and examination with slit lamp and dilated fundus examination. Results A total number of 25 cases were studied. Majority of the patients (25%) were in the age group of 60-69 years. Mean age was 46.8 years. Male to female ratio was 2.1:1. Left side of the face was involved in 14 (56%) patients and right side in 11 (44%) patients. Majority of the patients (60%) presented within 5 days of the onset of the disease. Out of 25 patients, 1 patient was known HIV seropositive and 3 patients were newly detected as HIV seropositive. Fifteen cases (60.0%) presented with best corrected visual acuity (BCVA) of 20/20, N6. Lid edema ranging from mild to severe and conjunctival hyperemia was noted in 19 cases (76.0%) at presentation. Corneal involvement in the form of decreased or absent sensation was noted in 13 cases (52%), 3 cases had dendritic ulcer (1.2%), 3 patients had stromal keratitis (1.2%) and 1 case had punctuate keratopathy (0.4%). Conclusion Our study outlines the varied clinical profile of herpes zoster ophthalmicus in north Karnataka. The higher incidence of lid edema is due to the application of mud over the lesions. Though low HIV seroprevalence is recorded in HZO patients, it is marginally high in young population. HZO may be taken as an indicator for HIV screening in younger population.References
Sterling JC. Viral infections. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. P. 33.25-27.
Liesegang TJ. Herpes zoster ophthalmicus - natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115:S3-S12.
Liesegang TJ. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. 1985;92:316-24.
Zaal MJ, Volker-Dieben HJ, Wienesen M, D'Amaro J, Kijlstra A. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus. Am J Ophthalmol. 2001;131:25-9.
Marsh RJ, Dulley B, Kelly V. External ocular motor palsies in ophthalmic zoster: a review. Br J Ophthalmol. 1977;61:677-82.
Harding SP, Lipton JR, Wells JC. Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol. 1987;71:353-8.
Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA. 1957;164:265-9.
De Moragas JM, Kierland RR. The outcome of patients with herpes zoster ophthalmicus. Arch Dermatol. 1957;75:193-6.
Bayu S, Alemayehu W. Clinical Profile of Herpes zoster ophthalmicus in Ethiopians. Clin Infect Dis. 1997;24:1256-60.
Karabassi M, Raizman MB, Schuman JS. Herpes zoster ophthalmicus. Surv Ophthalmol. 1992;36:395-410.
Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983;101:42-5.
Selliti TP, Huang AJ, Schiffmann J, Davis JL. Association of herpes zoster ophthalmicus with AIDS and acute retinal necrosis. Am J Ophthalmol. 1993;116:297-301.
Kestelyn P, Stevens AM, Bakkers E, Rouvroy D, Van de Perre P. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol. 1987;71:806-9.
Sujatha V, Padmajothi MS, Ambika H, Sujatha C. Herpes zoster ophthalmicus: clinical profile in adults less than 30 years of age. Our Dermatol Online. 2012;3:5-8
Gupta N, Sachdev R, Sinha R, Titiyal JS, Tandon R. Herpes zoster ophthalmicus: Disease spectrum in young adults. Middle East Afr J Ophthalmol. 2011;18:178-82.
Marsh RJ, Copper M. Ophthalmic herpes zoster. Eye. 1993;7:350-70.